Applied Nutrition Plc (LON:APN)
London · Delayed Price · Currency is GBP · Price in GBX 333.00
-1.00 (-0.30%)
Aug 14, 2026, 4:47 PM GMT
Applied Nutrition Income Statement
Financials in millions GBP. Fiscal year is August - July.
Millions GBP. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| 134 | 107.1 | 86.2 | 60.78 | 35.23 | 21.81 | |
Revenue Growth | 51.58% | 24.25% | 41.82% | 72.54% | 61.51% | 94.76% |
Cost of Revenue | 72.2 | 57.8 | 44.9 | 33.81 | 18.65 | 10.28 |
Gross Profit | 61.8 | 49.3 | 41.3 | 26.97 | 16.58 | 11.53 |
Selling, General & Admin | 22.8 | 19.5 | 16.4 | 9.3 | 6.8 | 4.5 |
Other Operating Expenses | - | - | - | - | - | -0.03 |
Operating Expenses | 22.8 | 19.5 | 16.4 | 9.3 | 6.8 | 4.47 |
Operating Income | 39 | 29.8 | 24.9 | 17.67 | 9.78 | 7.07 |
Interest Expense | -0.2 | -0.1 | -0.1 | - | -0.02 | -0.03 |
Interest & Investment Income | 0.5 | 0.5 | 0.7 | 0.07 | - | - |
EBT Excluding Unusual Items | 39.3 | 30.2 | 25.5 | 17.74 | 9.76 | 7.04 |
Other Unusual Items | -1.7 | -1.7 | -1.2 | - | - | - |
Pretax Income | 37.6 | 28.5 | 24.3 | 17.74 | 9.76 | 7.04 |
Income Tax Expense | 10 | 7.4 | 5.6 | 4.11 | 1.67 | 1.2 |
Net Income | 27.6 | 21.1 | 18.7 | 13.63 | 8.08 | 5.84 |
Net Income to Common | 27.6 | 21.1 | 18.7 | 13.63 | 8.08 | 5.84 |
Net Income Growth | 80.39% | 12.83% | 37.15% | 68.65% | 38.38% | 49.60% |
Shares Outstanding (Basic) | 250 | 250 | 250 | 5 | - | - |
Shares Outstanding (Diluted) | 250 | 250 | 250 | 5 | - | - |
Shares Change | 0.08% | - | 4900.00% | - | - | - |
EPS (Basic) | 0.11 | 0.08 | 0.07 | 2.73 | - | - |
EPS (Diluted) | 0.11 | 0.08 | 0.07 | 2.73 | - | - |
EPS Growth | 82.18% | 12.83% | -97.26% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Free Cash Flow | 15.9 | 14.6 | 5.7 | 7.35 | 6.04 | 2.25 |
Free Cash Flow Per Share | 0.06 | 0.06 | 0.02 | 1.47 | - | - |
Gross Margin | 46.12% | 46.03% | 47.91% | 44.37% | 47.06% | 52.88% |
Operating Margin | 29.10% | 27.82% | 28.89% | 29.08% | 27.76% | 32.41% |
Profit Margin | 20.60% | 19.70% | 21.69% | 22.43% | 22.95% | 26.78% |
Free Cash Flow Margin | 11.87% | 13.63% | 6.61% | 12.08% | 17.14% | 10.31% |
EBITDA | 40.1 | 30.6 | 25.5 | 18.08 | 10.04 | 7.3 |
EBITDA Margin | 29.93% | 28.57% | 29.58% | 29.75% | 28.49% | 33.46% |
D&A For EBITDA | 1.1 | 0.8 | 0.6 | 0.41 | 0.26 | 0.23 |
EBIT | 39 | 29.8 | 24.9 | 17.67 | 9.78 | 7.07 |
EBIT Margin | 29.10% | 27.82% | 28.89% | 29.08% | 27.76% | 32.41% |
Effective Tax Rate | 26.60% | 25.96% | 23.04% | 23.15% | 17.16% | 17.03% |